Team
Arkuda is comprised of passionate and experienced team members who are dedicated to improving the lives of people affected by neurodegenerative disease. Armed with deep expertise in biology and the ability to understand the root cause of disease, we are discovering medicines with the potential to positively change the trajectory of neurodegeneration.
Andy Hu, MD,
Chief Business Officer
Serena Hung, MD,
Chief Medical Officer
Duane Burnett, PhD,
Chief Technology Officer
GERHARD KOENIG, PHD,
Co-founder, President and CEO
Betsy Kassler,
Senior Director, Human Resources
Raymond Hurst, PhD,
Senior Vice President, Discovery
Mike Esposito, MSF,
Vice President, Finance
Irena Webster, MPH,
Vice President, Program Strategy & Dev Ops
Anna-Maria Alves, MS,
Associate Scientist
Giuseppe Astarita, PhD,
Senior Director, Biomarker Dx
Jean-François Blain, PhD,
Vice President, Neurobiology
Morgan Brand, PhD,
Associate Scientist
Angela Chen, MS,
Scientist II
Richard Gallegos,
Principal Scientist, DMPK
Gennifer Greenberg,
Senior Research Associate
Shawna Henry, PhD,
Scientist I
Christopher Holler, PhD,
Principal Scientist
Deliwe Jalbert, MBA,
Executive Assistant
Jim Lanter, PhD,
Vice President, Medicinal Chemistry
Stephanie McTighe, PhD,
Director, Pharmacology
Ingrid Ochoa,
Lab/Facility Manager
Xiaowen Peng, PhD,
Director, Medicinal Chemistry
Denise Peters,
Accounting Controller
John Ross, MS, RLATG, DSP, DABT,
Associate Director, Toxicology
Bonne Thompson,
Scientist II, Mass Spectrometry
Hillary Van Voorhies, MS,
Director, Program Management
Katie Watters, PhD,
Scientist I
Mary Wozniak,
Senior Research Associate
